X
TMC inches closer to inclisiran approval with long-term safety data
https://pharmaphorum.com/news/tmc-inches-closer-to-inclisiran-approval-with-long-term-safety-data/
cholesterol
Merck axes cholesterol drug despite phase 3 success
Merck & Co has said it will not file anacetrapib with regulators
Merck & Co hit by GoldenEye ransomware
Attack overshadows surprise success for cholesterol drug
Court bans US sales of Sanofi cholesterol drug
Amgen looks to corner PCSK9 market after patent win.
Pfizer’s hopes for cholesterol blockbuster dashed
Sales of cancer drug Ibrance also fall short of expectations.
Amgen’s cholesterol drug gets new monthly dose
Amgen searching for advantage over Sanofi rival.